BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 8609263)

  • 1. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.
    Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart T; Swinyer L; Whitmore C; Baker M; Czernielewski J
    J Am Acad Dermatol; 1996 Mar; 34(3):482-5. PubMed ID: 8609263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
    Ioannides D; Rigopoulos D; Katsambas A
    Br J Dermatol; 2002 Sep; 147(3):523-7. PubMed ID: 12207595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].
    Alirezai M; Meynadier J; Jablonska S; Czernielewski J; Verschoore M
    Ann Dermatol Venereol; 1996; 123(3):165-70. PubMed ID: 8761775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life.
    Grosshans E; Marks R; Mascaro JM; Torras H; Meynadier J; Alirezai M; Finlay AY; Soto P; Poncet M; Verschoore M; Clucas A
    Br J Dermatol; 1998 Oct; 139 Suppl 52():26-33. PubMed ID: 9990418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
    Thiboutot D; Gold MH; Jarratt MT; Kang S; Kaplan DL; Millikan L; Wolfe J; Loesche C; Baker M
    Cutis; 2001 Oct; 68(4 Suppl):10-9. PubMed ID: 11845943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris.
    Ellis CN; Millikan LE; Smith EB; Chalker DM; Swinyer LJ; Katz IH; Berger RS; Mills OH; Baker M; Verschoore M; Loesche C
    Br J Dermatol; 1998 Oct; 139 Suppl 52():41-7. PubMed ID: 9990420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.
    Cunliffe WJ; Danby FW; Dunlap F; Gold MH; Gratton D; Greenspan A
    Eur J Dermatol; 2002; 12(4):350-4. PubMed ID: 12095880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients.
    Caron D; Sorba V; Kerrouche N; Clucas A
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S110-2. PubMed ID: 9204087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients.
    Clucas A; Verschoore M; Sorba V; Poncet M; Baker M; Czernielewski J
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S116-8. PubMed ID: 9204089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris.
    Kakita L
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S51-4. PubMed ID: 10898831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV).
    Tirado-Sánchez A; Espíndola YS; Ponce-Olivera RM; Bonifaz A
    J Cosmet Dermatol; 2013 Jun; 12(2):103-7. PubMed ID: 23725303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adapalene gel 0.1%: effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients.
    Zhu XJ; Tu P; Zhen J; Duan YQ
    Cutis; 2001 Oct; 68(4 Suppl):55-9. PubMed ID: 11845949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.
    Piérard-Franchimont C; Henry F; Fraiture AL; Fumal I; Piérard GE
    Dermatology; 1999; 198(2):218-22. PubMed ID: 10325486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials.
    Cunliffe WJ; Caputo R; Dreno B; Förström L; Heenen M; Orfanos CE; Privat Y; Robledo Aguilar A; Meynadier J; Alirezai M; Jablonska S; Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart JM; Swinyer L; Whitmore C; Czernielewski J; Verschoore M
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S126-34. PubMed ID: 9204091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.
    Webster GF; Guenther L; Poulin YP; Solomon BA; Loven K; Lee J
    Cutis; 2002 Feb; 69(2 Suppl):4-11. PubMed ID: 12095066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population.
    Cook-Bolden FE; Weinkle SH; Guenin E; Bhatt V
    J Drugs Dermatol; 2019 Jan; 18(1):32-38. PubMed ID: 30681791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of adapalene gel 0.1% vs. tretinoin gel 0.025% in the treatment of acne vulgaris in China.
    Tu P; Li GQ; Zhu XJ; Zheng J; Wong WZ
    J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():31-6. PubMed ID: 11843231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference.
    Dunlap FE; Mills OH; Tuley MR; Baker MD; Plott RT
    Br J Dermatol; 1998 Oct; 139 Suppl 52():17-22. PubMed ID: 9990416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
    Egan N; Loesche MC; Baker MM
    Cutis; 2001 Oct; 68(4 Suppl):20-4. PubMed ID: 11845944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.